Clinical Trials Directory

Trials / Completed

CompletedNCT04764643

The Efficacy of N-acetylcysteine on Alleviating Symptom Caused by Lugol Chromoendoscopy

The Efficacy of N-acetylcysteine on Alleviating Symptom Caused by Lugol Chromoendoscopy: a Prospective, Non-inferiority, Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
140 (actual)
Sponsor
Xijing Hospital of Digestive Diseases · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Lugol chromoendoscopy is essential in detecting and characterizing squamous cell carcinoma of esophagus. Esophageal irritating symptom has been reported as an common adverse event, which could be alleviated by sodium thiosulfate solutions. However, sodium thiosulfate was not widely available. N-acetylcysteine has been previously used as a mucolytic reagent, we propose that it may also be used to alleviate irritating symptoms caused by Lugo's chromoendoscopy. A prospective, non-inferior, randomized double-blind clinical trial was designed to study the efficacy of N-acetylcysteine solutions in relieving esophageal discomfort .

Conditions

Interventions

TypeNameDescription
DRUGN-acetylcysteine solutionuse N-acetylcysteine solution to alleviate esophageal irritation caused by Lugol's chromoendoscopy
DRUGsodium thiosulfate solutionuse sodium thiosulfate solution to alleviate esophageal irritation caused by Lugol's chromoendoscopy

Timeline

Start date
2020-02-01
Primary completion
2021-04-30
Completion
2021-05-31
First posted
2021-02-21
Last updated
2023-01-30

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04764643. Inclusion in this directory is not an endorsement.